Correction: A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis
PLoS One. 2015 Nov 10;10(11):e0142802.
doi: 10.1371/journal.pone.0142802.
eCollection 2015.